Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Corcept Therapeutics (CORT) Return on Invested Capital (2018 - 2025)

Historic Return on Invested Capital for Corcept Therapeutics (CORT) over the last 9 years, with Q3 2025 value amounting to 0.12%.

  • Corcept Therapeutics' Return on Invested Capital fell 700.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12%, marking a year-over-year decrease of 700.0%. This contributed to the annual value of 0.2% for FY2024, which is 200.0% up from last year.
  • According to the latest figures from Q3 2025, Corcept Therapeutics' Return on Invested Capital is 0.12%, which was down 700.0% from 0.16% recorded in Q2 2025.
  • Corcept Therapeutics' Return on Invested Capital's 5-year high stood at 0.28% during Q1 2022, with a 5-year trough of 0.12% in Q3 2025.
  • For the 5-year period, Corcept Therapeutics' Return on Invested Capital averaged around 0.2%, with its median value being 0.19% (2021).
  • Its Return on Invested Capital has fluctuated over the past 5 years, first surged by 1000bps in 2022, then crashed by -1100bps in 2023.
  • Corcept Therapeutics' Return on Invested Capital (Quarter) stood at 0.24% in 2021, then decreased by -18bps to 0.2% in 2022, then fell by -6bps to 0.19% in 2023, then fell by -4bps to 0.18% in 2024, then crashed by -32bps to 0.12% in 2025.
  • Its Return on Invested Capital was 0.12% in Q3 2025, compared to 0.16% in Q2 2025 and 0.16% in Q1 2025.